Lennar Corporation · LEN · FY2026 Q2 · Calendar Q2 2026
Lennar Margins Recover as Incentives Fall, But Annual Volume Target Cut
Lennar's Q2 2026 results show sequential margin improvement and a milestone decline in sales incentives, but the company lowered its full-year delivery guidance as elevated mortgage rates and macro uncertainty persist. The asset-light land strategy and cost-reduction initiatives are gaining traction, yet the volume cut and a sharp post-earnings stock reaction indicate the market remains skeptical on near-term demand. EPS landed in line with consensus at $1.24, while revenue of $7.94 billion fell slightly below the $8.08 billion estimate.
Company context
Snapshot as of publicationLennar Corporation, an influential homebuilder in the United States, operates primarily under its widely recognized Lennar brand, alongside its various subsidiaries. The company structures its diverse business initiatives across several distinct divisions: regional homebuilding segments (East, Central, Texas, and West), a Financial Services arm, a Multifamily property development unit, and a broader "Lennar Other" category. At the heart of its operations, Lennar is deeply involved in the creation and sale of single-family homes, encompassing both attached and detached designs.…
Earnings scorecard
Reported versus consensusEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Citigroup | Neutral | Neutral | Maintain | Jul 15, 2026 |
| UBS | Neutral | Neutral | Maintain | Jun 16, 2026 |
| JP Morgan | Underweight | Underweight | Maintain | Jun 16, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jun 15, 2026 |
| RBC Capital | Underperform | Underperform | Maintain | Jun 15, 2026 |
| Evercore ISI Group | Underperform | Underperform | Maintain | Jun 15, 2026 |
| Barclays | Underweight | Underweight | Maintain | Jun 15, 2026 |
| B of A Securities | Underperform | Underperform | Maintain | Jun 15, 2026 |
| Keefe, Bruyette & Woods | Underperform | Market Perform | Downgrade | Jun 9, 2026 |
| Seaport Global | Sell | Buy | Downgrade | Apr 7, 2026 |
| Truist Securities | Hold | Hold | Maintain | Mar 31, 2026 |
| Citizens | Market Perform | Market Outperform | Downgrade | Jan 7, 2026 |
| Wedbush | Neutral | Neutral | Maintain | Sep 22, 2025 |
| Raymond James | Underperform | Market Perform | Downgrade | Sep 22, 2025 |
| JMP Securities | Market Outperform | Market Perform | Upgrade | Sep 22, 2025 |
| Zelman & Assoc | Neutral | Outperform | Downgrade | Jun 18, 2025 |
| Citizens Capital Markets | Market Outperform | Market Outperform | Maintain | Mar 31, 2025 |
| Goldman Sachs | Neutral | Neutral | Maintain | Mar 25, 2025 |
| BTIG | Neutral | Buy | Downgrade | Dec 20, 2024 |
| Argus Research | Buy | Buy | Maintain | Jun 27, 2024 |
| Oppenheimer | Perform | Perform | Maintain | Mar 15, 2024 |
| Deutsche Bank | Sell | Sell | Maintain | Jun 1, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Mar 16, 2023 |
| Keybanc | Overweight | Overweight | Maintain | Dec 16, 2022 |
| Wolfe Research | Outperform | Outperform | Maintain | Mar 16, 2021 |
| Susquehanna | Positive | Neutral | Upgrade | Sep 17, 2020 |
| CFRA | Hold | Hold | Maintain | May 11, 2020 |
| Buckingham Research | Buy | Buy | Maintain | Oct 3, 2019 |
| Buckingham | Buy | Buy | Maintain | Oct 3, 2019 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | Aug 13, 2019 |
| Bank of America | Buy | Buy | Maintain | Jun 26, 2019 |
| Argus | Buy | Buy | Maintain | Oct 15, 2018 |
| Maxim Group | Buy | Buy | Maintain | May 23, 2018 |
| Mizuho | Buy | Neutral | Upgrade | Jan 18, 2018 |
| MKM Partners | Buy | Neutral | Upgrade | Oct 4, 2017 |
| BTIG Research | Buy | Buy | Maintain | Oct 4, 2017 |
| Keefe Bruyette & Woods | Outperform | Outperform | Maintain | Sep 21, 2016 |
| Sterne Agee CRT | Buy | Neutral | Upgrade | Jan 19, 2016 |
| Sterne Agee | Buy | Neutral | Upgrade | Jan 19, 2016 |
| FBR Capital | Outperform | Outperform | Maintain | Sep 22, 2015 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jan 15, 2015 |
| Compass Point | Neutral | Neutral | Maintain | Oct 13, 2014 |
| CRT Capital | Buy | Hold | Upgrade | Jun 27, 2013 |
| FBN Securities | Sector Perform | Underperform | Upgrade | Apr 3, 2013 |
| Williams Capital | Buy | Buy | Maintain | Jan 16, 2013 |
| Topeka | Hold | Hold | Maintain | Dec 7, 2012 |
| ISI Group | Buy | Buy | Maintain | Sep 25, 2012 |
| Williams Financial | Buy | Buy | Maintain | May 17, 2012 |
| Guggenheim | Neutral | Neutral | Maintain | Mar 27, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $83.75. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Argus Research | Christopher Graja | $108 | $84.76 | +29.0% | Jul 9, 2026 |
| UBS | John Lovallo | $94 | $89.75 | +12.2% | Jun 16, 2026 |
| RBC Capital | Analyst unavailable | $85 | $91.91 | +1.5% | Jun 15, 2026 |
| BTIG | Analyst unavailable | $67 | $90.3 | -20.0% | Jun 15, 2026 |
| Wells Fargo | Analyst unavailable | $85 | $90.3 | +1.5% | Jun 15, 2026 |
| Barclays | Analyst unavailable | $79 | $90.3 | -5.7% | Jun 15, 2026 |
| BTIG | Analyst unavailable | $73 | $90.49 | -12.8% | Jun 8, 2026 |
| Goldman Sachs | Analyst unavailable | $125 | $120.9 | +49.3% | Jan 13, 2026 |
| RBC Capital | Analyst unavailable | $88 | $109.55 | +5.1% | Jan 9, 2026 |
| UBS | John Lovallo | $122 | $105.4 | +45.7% | Jan 6, 2026 |
| UBS | John Lovallo | $137 | $109.32 | +63.6% | Dec 18, 2025 |
| Goldman Sachs | Susan Maklari | $120 | $112.23 | +43.3% | Dec 18, 2025 |
| BTIG | Analyst unavailable | $90 | $112.23 | +7.5% | Dec 18, 2025 |
| Wells Fargo | Analyst unavailable | $110 | $112.23 | +31.3% | Dec 18, 2025 |
| Barclays | Matthew Bouley | $88 | $112.23 | +5.1% | Dec 18, 2025 |
| Evercore ISI | Analyst unavailable | $92 | $112.23 | +9.9% | Dec 18, 2025 |
| RBC Capital | Analyst unavailable | $95 | $112.23 | +13.4% | Dec 17, 2025 |
| Barclays | Matthew Bouley | $98 | $123.91 | +17.0% | Dec 8, 2025 |
| Evercore ISI | Analyst unavailable | $114 | $126.39 | +36.1% | Oct 7, 2025 |
| JMP Securities | Aaron Hecht | $140 | $127.32 | +67.2% | Sep 22, 2025 |
| Wells Fargo | Analyst unavailable | $135 | $132.68 | +61.2% | Sep 2, 2025 |
| Barclays | Analyst unavailable | $110 | $117.56 | +31.3% | Mar 24, 2025 |
| Wells Fargo | Sam Reid | $190 | $182.25 | +126.9% | Oct 7, 2024 |
| Evercore ISI | Stephen Kim | $236 | $185.8 | +181.8% | Sep 24, 2024 |
| Bank of America Securities | Rafe Jadrosich | $190 | $185.3 | +126.9% | Sep 23, 2024 |
| Citigroup | Anthony Pettinari | $196 | $184.62 | +134.0% | Sep 23, 2024 |
| BTIG | Carl Reichardt | $216 | $182.19 | +157.9% | Sep 23, 2024 |
| RBC Capital | Mike Dahl | $160 | $184.87 | +91.0% | Sep 23, 2024 |
| Goldman Sachs | Susan Maklari | $190 | $182.19 | +126.9% | Sep 23, 2024 |
| Goldman Sachs | Susan Maklari | $182 | $192.45 | +117.3% | Sep 20, 2024 |
| Wells Fargo | Sam Reid | $205 | $179.42 | +144.8% | Sep 9, 2024 |
| Goldman Sachs | Susan Maklari | $174 | $170.94 | +107.8% | Jul 22, 2024 |
| RBC Capital | Mike Dahl | $145 | $148.72 | +73.1% | Jun 20, 2024 |
| Goldman Sachs | Susan Maklari | $180 | $148.72 | +114.9% | Jun 20, 2024 |
| Evercore ISI | Stephen Kim | $237 | $148.72 | +183.0% | Jun 20, 2024 |
| Barclays | Matthew Bouley | $177 | $148.72 | +111.3% | Jun 20, 2024 |
| Citigroup | Anthony Pettinari | $183 | $153.06 | +118.5% | Jun 14, 2024 |
| Wedbush | Jay McCanless | $144 | $153.95 | +71.9% | Jun 10, 2024 |
| Argus Research | Chris Graja | $175 | $160.27 | +109.0% | Apr 11, 2024 |
| Jefferies | Collin Verron | $144 | $156.57 | +71.9% | Mar 15, 2024 |
| UBS | John Lovallo | $198 | $156.57 | +136.4% | Mar 15, 2024 |
| Wells Fargo | Deepa Raghavan | $175 | $156.57 | +109.0% | Mar 15, 2024 |
| Evercore ISI | Stephen Kim | $238 | $156.57 | +184.2% | Mar 15, 2024 |
| Raymond James | Buck Horne | $165 | $148.23 | +97.0% | Dec 19, 2023 |
| Citigroup | Anthony Pettinari | $139 | $115.97 | +66.0% | Sep 14, 2023 |
| Wedbush | Jay McCanless | $94 | $116.46 | +12.2% | Jun 13, 2023 |
| Citigroup | Anthony Pettinari | $113 | $98.96 | +34.9% | Mar 14, 2023 |
| RBC Capital | Analyst unavailable | $79 | $93.18 | -5.7% | Dec 16, 2022 |
| J.P. Morgan | Analyst unavailable | $97 | $84.26 | +15.8% | Nov 22, 2022 |
| JMP Securities | Aaron Hecht | $115 | $80.5 | +37.3% | Oct 4, 2022 |
| Barclays | Matthew Bouley | $85 | $69.64 | +1.5% | Jun 29, 2022 |
| Wedbush | Jay McCanless | $88 | $69.48 | +5.1% | Jun 29, 2022 |
| Raymond James | Buck Horne | $75 | $69.64 | -10.4% | Jun 29, 2022 |
| Evercore ISI | Stephen Kim | $112 | $69.64 | +33.7% | Jun 29, 2022 |
| UBS | John Lovallo | $108 | $69.64 | +29.0% | Jun 29, 2022 |
| KeyBanc | Kenneth Zener | $60 | $69.64 | -28.4% | Jun 29, 2022 |
| BTIG | Carl Reichardt | $97 | $72.04 | +15.8% | Jun 28, 2022 |
| UBS | John Lovallo | $154 | $82.51 | +83.9% | Mar 28, 2022 |
| BTIG | Carl Reichardt | $118 | $88.22 | +40.9% | Mar 21, 2022 |
| KeyBanc | Kenneth Zener | $75 | $86.27 | -10.4% | Mar 15, 2022 |
| Goldman Sachs | Susan Maklari | $140 | $92.02 | +67.2% | Feb 16, 2022 |
| KeyBanc | Kenneth Zener | $86 | $96.86 | +2.7% | Jan 19, 2022 |
| Seaport Global | Mark Weintraub | $133 | $107.74 | +58.8% | Jan 14, 2022 |
| Raymond James | Buck Horne | $125 | $108.3 | +49.3% | Dec 21, 2021 |
| Argus Research | Chris Graja | $120 | $105.4 | +43.3% | Dec 20, 2021 |
| JMP Securities | Aaron Hecht | $130 | $105.43 | +55.2% | Dec 17, 2021 |
| Wedbush | Jay McCanless | $130 | $105.43 | +55.2% | Dec 17, 2021 |
Track every rating change on LEN the moment it posts. Free to start.
Start freeMarket reaction
event-close to next-session closeFollow LEN with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Gross margin rose to 15.6% from 15.2% in Q1, which management had called the low point for the year. The sales incentive rate dropped to 12.9% after three consecutive years of increases — a potential inflection point for profitability. Deliveries of 20.5k homes and new orders of 21.7k met the prior guidance range. However, management lowered the full-year delivery target from 85,000 to 82,000–83,000 homes. The stock fell sharply after the report, with an abnormal move of -5.4% and continued drift of -7.3% over subsequent sessions on volume 2.4x the baseline.
Guidance delta
Lennar lowered its full-year delivery target to 82,000–83,000 homes from the prior 85,000-home goal, citing elevated mortgage rates and macro uncertainty. Q3 guidance calls for 20,500–21,500 deliveries at an average sales price of $375,000–$380,000 and gross margin of approximately 16%. Guidance sentiment shifted from maintained to lowered quarter-over-quarter.
Key takeaways
- Q2 deliveries reached 20.5k homes with 21.7k new orders; gross margin improved to 15.6% and net margin to 6.4%.
- Sales incentive rate declined to 12.9% — the first drop after three consecutive years of increases — signaling early margin recovery.
- Asset-light model deepened: only 2% of land sits on the balance sheet, inventory turn reached 2.5x, and cycle time fell to a record low of 121 days.
- Full-year delivery guidance was lowered to 82–83k homes from the prior 85k target due to elevated rates and macro uncertainty.
- Balance sheet remains strong with $1.8 billion in cash, homebuilding debt at 15.8% of capital, $447 million in share repurchases, and $123 million in dividends.
Management priorities
- Expand the share of core product across geographies to reduce cycle time and construction cost per square foot
- Deepen the land-bank partnership model to improve capital efficiency and lower weighted average cost of capital
- Deploy technology investments to reduce SG&A and enhance the customer experience
- Monitor and adapt to potential federal housing-affordability initiatives
- Sustain inventory-turn improvement and continue margin recovery
Related earnings events
Consumer CyclicalSources
- Earnings call transcript and parsed analysis · 2026-06-12T22:22:56.476598+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-31T01:21:10.899535+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-31T01:21:10.896615+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.